Image de couverture de livre

Functional biomarkers for sickle cell disease

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteur principal:	Yvette C. Tanhehco
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Transfusion
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Clinics and genetics of hyperhemolysis syndrome in patients with sickle cell disease
par: Barbara Malta, et autres
Publié: (2025)

Chronic automated red cell exchange therapy for sickle cell disease
par: Abdulhafiz Zakieh, et autres
Publié: (2024)

Red cell exchange removes apixaban in patients with sickle cell disease
par: Kimberly Boyle, et autres
Publié: (2026)

Alloimmunization as a barrier to gene therapy in sickle cell disease
par: Hannah R. Abrams, et autres
Publié: (2025)

Strategies to mitigate transfusion‐associated red blood cell alloimmunization in sickle cell disease: A retrospective analysis
par: Elizabeth P. Crowe, et autres
Publié: (2025)

Prevalence of red blood cell alloantibodies in pregnant women with sickle cell disease in Bamako
par: Minkoro Fomba, et autres
Publié: (2024)

Longitudinal outcomes of chronically transfused adults with sickle cell disease and a history of childhood stroke
par: Jennifer M. Jones, et autres
Publié: (2024)

Outcomes on the use of hyperhemolysis prophylaxis in pediatric sickle cell disease patients with history of hyperhemolysis syndrome
par: HyoJeong Han, et autres
Publié: (2025)

Transfusion utilization during gene therapy for sickle cell disease: A single institution experience
par: Ross M. Fasano, et autres
Publié: (2026)

Survival of transfused red blood cells from a donor with alpha‐thalassemia trait in a recipient with sickle cell disease
par: Marianne E. M. Yee, et autres
Publié: (2024)

RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA
par: Narek Israelyan, et autres
Publié: (2024)

Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited
par: Gabriel André Leiva‐Torres, et autres
Publié: (2024)

Post‐exchange neutrophil count, but not post‐hematocrit, predicts endogenous erythropoiesis in patients with sickle cell disease undergoing chronic red cell exchange
par: Nalan Yurtsever, et autres
Publié: (2024)

Development of an interactive mapping tool to estimate where resources for people living with sickle cell disease may be needed most
par: Kendall Werneiwski, et autres
Publié: (2024)

What is the best approach to blood transfusion in sickle cell disease? A scientometric analysis and literature review
par: Christiane Ruffato Carminati, et autres
Publié: (2026)

Adding hydroxyurea to chronic transfusion therapy for sickle cell anemia reduces transfusion burden
par: Robert Sheppard Nickel, et autres
Publié: (2024)

A novel acridine flow cytometry marker to track post‐transfusion amustaline/glutathione pathogen‐reduced red blood cell survival in sickle cell disease patients
par: Richard J. Benjamin, et autres
Publié: (2025)

How we implement a prehospital transfusion program
par: Emily Coberly, et autres
Publié: (2025)

Carbon monoxide treatment rescues leukofiltration and preserves storage quality of red blood cell concentrates from sickle cell trait donors
par: Sofiane Driouche, et autres
Publié: (2026)

The effect of limited donor phenotyped blood transfusion on alloimmunisation in children with thalassaemia and sickle cell anaemia
par: Menna Allah Zakaria Mohammad Ali Abou Elwafa, et autres
Publié: (2026)

Burden of transfusion‐transmitted infections among patients with thalassaemia and sickle cell anaemia in India: A systematic review and meta‐analysis
par: Vaibhav Shandilya, et autres
Publié: (2025)

Characterization of the alcohol biomarker phosphatidylethanol in donor whole blood and apheresis red blood cells: Implications for transfusion recipients
par: Theresa N. Kinard, et autres
Publié: (2024)

In reply: Considering the reporting of race in the transfusion medicine literature
par: Richard L. Haspel, et autres
Publié: (2024)

In response: Approach to autologous stem cell harvesting and transplantation in patients with cold‐agglutinin disease or cryoglobulins
par: Rachel Pawson, et autres
Publié: (2025)

High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality
par: Zachary M. Avigan, et autres
Publié: (2024)

Approach to autologous stem cell transplantation in a patient with severe cold agglutinin disease, a case report
par: Mathias Castonguay, et autres
Publié: (2025)

A critical moment: Standardizing red blood cell antibody reporting to reduce hemolytic disease of the fetus and newborn risk
par: Molly Sherwood, et autres
Publié: (2026)

Association of endotheliopathy and coagulopathy biomarkers with survival in a swine model of isolated uncontrolled hemorrhage
par: Alan Weaver, et autres
Publié: (2026)

Method comparison between hematopoietic progenitor cell and CD34+ cell counts in hematopoietic stem cell collection
par: Thibault Lavalleye, et autres
Publié: (2024)

Platelets visible in automated red cell exchange waste bag
par: A. Javanbakht, et autres
Publié: (2024)

Healthcare center‐based cell therapy laboratories supporting off‐site manufactured cell therapies: The experiences of a single academic cell therapy laboratory
par: Anh Dinh, et autres
Publié: (2024)

Suppression of RBC alloimmunization and regulation of CD4 + T cell dependence by C3 is not due to genetic confounders in mice
par: Arijita Jash, et autres
Publié: (2025)

Functional effects of an African glucose‐6‐phosphate dehydrogenase (G6PD) polymorphism (Val68Met) on red blood cell hemolytic propensity and post‐transfusion recovery
par: Ling Wang, et autres
Publié: (2024)

Deglycerolization of manually glycerolized, frozen red cell concentrates using a closed system cell processor
par: Anita Howell, et autres
Publié: (2025)

Rare antigen‐negative red blood cells from pluripotent stem cells for precision transfusion medicine
par: Naomi Gunawardena, et autres
Publié: (2026)

Increased platelet to red blood cell transfusion ratio associated with acute kidney injury in children with life‐threatening bleeding
par: Rachel Vaizer, et autres
Publié: (2024)

Prediction of CD34+ hematopoietic stem cells in healthy allogeneic stem cell donors on the Optia cell separator based on CE2: Which formula is more correlated with actual CD34+?
par: Sıdıka Gülkan Özkan, et autres
Publié: (2024)

Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation
par: Moazzam Shahzad, et autres
Publié: (2024)

Successful re‐infusion of hepatitis E contaminated stem cells during autologous stem cell transplantation with ribavirin prophylaxis
par: Hannah Sadler, et autres
Publié: (2026)

Re‐scanning the transfusion‐transmitted disease horizon
par: Richard M. Kaufman
Publié: (2024)